Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Clinical trial NCT06008119 · RECRUITING
Trial details
- NCT number
- NCT06008119
- Sponsor
- Shanghai Kechow Pharma, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2026-12-24
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.